insulin - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
Product details |
Supply Impact Dates |
Further Details |
HUMULIN 30/70 biosynthetic human 30% neutral 70% isophane insulin 100IU/mL injection 10mL vial AUST R: 39656Active ingredients:
insulin
Dosage form: Injection, suspension
Sponsor: Eli Lilly Australia Pty Ltd
Phone: 1800454559
|
From 23 Oct 2023 to 14 Jun 2024
|
Shortage status: Current
Availability: Limited Availability
Reason: Manufacturing
Management action: Alternative brand available.
|
MIXTARD 30/70 INNOLET human insulin (rys) 100IU/mL injection multidose cartridge AUST R: 169628Active ingredients:
insulin
Dosage form: Injection, suspension
Sponsor: Novo Nordisk Pharmaceuticals Pty Ltd
Phone: 1800 668 626
|
Deletion from market:
31 Jul 2024
|
Shortage status: To be discontinued
Availability: Unavailable
Reason: Commercial Changes / Commercial viability
|
MIXTARD 30/70 PENFILL human insulin (rys) 100IU/mL injection multidose cartridge AUST R: 169629Active ingredients:
insulin
Dosage form: Injection, suspension
Sponsor: Novo Nordisk Pharmaceuticals Pty Ltd
Phone: 1800 668 626
|
Deletion from market:
01 Feb 2025
|
Shortage status: To be discontinued
Availability: Unavailable
Reason: Commercial Changes / Commercial viability
Management action: Alternative brand available
|
MIXTARD 50/50 PENFILL human insulin (rys) 100IU/mL injection multidose cartridge AUST R: 169630Active ingredients:
insulin
Dosage form: Injection, suspension
Sponsor: Novo Nordisk Pharmaceuticals Pty Ltd
Phone: 1800 668 626
|
Deletion from market:
31 May 2023
|
Shortage status: Discontinued
Availability: Unavailable
Reason: Commercial Changes / Commercial viability
Management action: Other strengths are available.
|